challeng path ahead downgrad
disclos one patient dose vg/kg high dose
patient treatment-rel sae due transient elev liver
transaminas transient increas bilirubin upper limit
normal resolv oral steroid separ patient
treatment relat declin platelet count deem non-seri ae
sae due gastrointestin infect unrel studi drug
recal first patient treat low dose vg/kg experienc
signific platelet declin innat immun system activ classifi
sae see solid bioscienc wait lead program firm
led modif protocol includ requir iv
glucocorticoid initi week follow administr
specif soliri avail treatment option
event complement activ
downgrad under-perform neutral enrol
challeng pressur timelin ahead earlier year solid
present underwhelm initi microdystrophin data patient
low dose necessit dose escal vg/kg vg/kg
anoth treatment-rel sae expect enrol high dose may
prove challeng note improv efficaci higher dose
could off-set ae issu promis initi data sarepta posit
commentari gene tx program limit upsid expect
cash hand solid fund oper earli could delay
manufactur scale-up timelin caus program fall
behind peer even approv believ potenti
requir soliri may hurt competit vs peer
lower target price dcf valuat assum
po ep vs old upsid risk includ
clinic success stand-alon valu solid gt facil
valuat metric
number share
rate neutral under-perform
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
clinic stage biotechnolog compani focus
develop therapi treat duchenn muscular dystrophi
dmd compani lead product candid gene
therapi clinic develop treat dmd
price may rate neutral under-perform target price analyst martin
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
blue sky scenario assum probabl
success dmd gene therapi
market share market share
 close
grey sky scenario reflect stock trade cash
event fail clinic develop
compani mention price
